Literature DB >> 6385655

Pharmacokinetic and metabolic characteristics of ticlopidine in relation to its inhibitory properties on platelet function.

C Picard-Fraire.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6385655

Source DB:  PubMed          Journal:  Agents Actions Suppl        ISSN： 0379-0363


× No keyword cloud information.
  11 in total

1.  Pharmacodynamics of ticlopidine in man in relation to plasma and blood cell concentration.

Authors:  T DiPerri; F L Pasini; C Frigerio; P Blardi; F Centini; G L Messa; A Ghezzi; L Volpi
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  The P2Y(12) receptor as a target of antithrombotic drugs.

Authors:  Stephen O'Connor; Gilles Montalescot; Jean-Philippe Collet
Journal:  Purinergic Signal       Date:  2011-06-28       Impact factor: 3.765

3.  Structures of cytochrome P450 2B4 complexed with the antiplatelet drugs ticlopidine and clopidogrel .

Authors:  Sean C Gay; Arthur G Roberts; Keiko Maekawa; Jyothi C Talakad; Wen-Xu Hong; Qinghai Zhang; C David Stout; James R Halpert
Journal:  Biochemistry       Date:  2010-09-15       Impact factor: 3.162

Review 4.  Ticlopidine. An updated review of its pharmacology and therapeutic use in platelet-dependent disorders.

Authors:  D McTavish; D Faulds; K L Goa
Journal:  Drugs       Date:  1990-08       Impact factor: 9.546

5.  Identification of the Significant Involvement and Mechanistic Role of CYP3A4/5 in Clopidogrel Bioactivation.

Authors:  Yaoqiu Zhu; Jiang Zhou
Journal:  ACS Med Chem Lett       Date:  2012-09-09       Impact factor: 4.345

6.  Structure and function of cytochromes P450 2B: from mechanism-based inactivators to X-ray crystal structures and back.

Authors:  James R Halpert
Journal:  Drug Metab Dispos       Date:  2011-04-18       Impact factor: 3.922

7.  Single and multiple dose pharmacokinetics of ticlopidine in young and elderly subjects.

Authors:  J Shah; P Teitelbaum; B Molony; T Gabuzda; I Massey
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

Review 8.  Pharmacokinetic optimisation of the treatment of embolic disorders.

Authors:  D M Lutomski; M Bottorff; K Sangha
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

Review 9.  Ticlopidine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states.

Authors:  E Saltiel; A Ward
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

Review 10.  Clinical pharmacokinetics of ticlopidine.

Authors:  J P Desager
Journal:  Clin Pharmacokinet       Date:  1994-05       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.